Among the main CKM components, the mediation proportions were 30.5 % for predicted 10-year CVD risk, 13.0 % for HOMA-IR, and 17.0 % for CKD risk, respectively (Fig. 4). This evidence concerns the gene CKM and chronic kidney disease.